Pricing Log in Create free account

SAB Biotherapeutics, Inc. (SABS) vs Turn Therapeutics Inc. (TTRX)

SAB Biotherapeutics, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. SAB Biotherapeutics, Inc. and Turn Therapeutics Inc. are of similar size ($273.0M and $267.5M). Across the 10 metrics below, SAB Biotherapeutics, Inc. leads on 6 and Turn Therapeutics Inc. on 4.

Valuation

Metric SABS TTRX Biotechnology median
P/E n/m n/m 10.60
P/S 147.02 n/m 9.40
P/B 1.11 403.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 85.82 n/m 9.02
Earnings yield (6.31%) (3.12%) (32.88%)
Free cash flow yield (24.01%) (1.61%) (23.13%)

Profitability

Metric SABS TTRX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (34.27%) (3,315.33%) (51.96%)
Return on assets (28.97%) (99.59%) (46.06%)
Return on invested capital (38.97%) 0.00% 0.00%

Growth

Metric SABS TTRX Biotechnology median
Revenue growth (TTM) (60.26%) — 6.76%
EPS growth (last fiscal year) 78.53% (80.72%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR (26.69%) — 0.00%

Health

Metric SABS TTRX Biotechnology median
Debt to equity 0.01 8.83 0.00
Current ratio 9.22 1.19 4.97
Net debt to EBITDA 2.03 0.96 1.01

Dividend

Metric SABS TTRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SABS TTRX Biotechnology median
Market cap 267.50m 272.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack